| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 09/03/1992 | WO1992014743A2 Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane |
| 09/03/1992 | WO1992014737A1 3-desmethylrapamycin or derivatives thereof, processes for their preparation and their use as antifungal agents and immunosuppressants |
| 09/03/1992 | WO1992014707A1 Poly-4-aminopyrrole-2-carboxyamide derivatives, processes for their preparation and pharmaceutical compositions which contain them |
| 09/03/1992 | WO1992014487A1 Preparation and use of formalin-killed colonization-factor-antigen (cfa)-expressing e. coli organisms for vaccination against enteric infection/diarrhea caused by enterotoxigenic e. coli bacteria in humans |
| 09/03/1992 | WO1992014484A1 Methods and compositions for the treatment of infection and control of flora |
| 09/03/1992 | WO1992014462A1 Cytokine inhibitors |
| 09/03/1992 | WO1992014458A1 Benzopyran phenol derivates for use as antibacterial, antiviral or immunostimulating agents |
| 09/03/1992 | WO1992014450A1 Sustained release drug delivery devices |
| 09/02/1992 | EP0500893A1 Preservation of blood, tissues and biological fluids |
| 09/02/1992 | EP0500791A1 The design and construction of non-infectious human retroviral mutants deficient in genomic rna |
| 09/02/1992 | EP0500699A1 Cross-protective salmonella vaccines |
| 09/02/1992 | EP0500686A1 Tricyclic 6,5,5]/ 6,6,5]-fused oxazolidinone antibacterial agents. |
| 09/02/1992 | EP0500653A1 Inhibitors of purine nucleoside phosphorylase |
| 09/02/1992 | EP0500610A1 Nucleoside derivatives |
| 09/01/1992 | US5144037 Viricides |
| 09/01/1992 | US5143911 Bactericides |
| 09/01/1992 | US5143910 Piperaziniocephalosporins |
| 09/01/1992 | CA1306944C Lithium salt-containing pharmaceutical compositions |
| 09/01/1992 | CA1306943C Blood products for parenteral administration |
| 08/29/1992 | WO1992015601A2 Heteroanthracycline antitumor analogs |
| 08/29/1992 | WO1992015310A1 Use of tricyclic isoindolinones as antiviral drugs, and new, optically active isoindolinones |
| 08/29/1992 | CA2104963A1 Use of tricyclic isoindolinones as anti-viral medicaments as well as new optically-active isoindolinones |
| 08/29/1992 | CA2104768A1 Heteroanthracycline antitumor analogs |
| 08/29/1992 | CA2104285A1 Recombinant fiv glycoprotein 160 and p24 gag protein |
| 08/26/1992 | EP0500387A2 Methods and compositions for the treatment of infection and control of flora using haloperoxidase |
| 08/26/1992 | EP0500170A2 Cyclic hexapeptides having antibiotic activity |
| 08/26/1992 | EP0500143A2 Pharmaceutical composition comprising an aminoglycoside phosphate |
| 08/26/1992 | EP0499834A2 A blood-stage antigen from Plasmodium falciparum, its preparation and use |
| 08/26/1992 | EP0246322B1 Treatment of aids-type disease |
| 08/25/1992 | US5142056 Human immunodeficiency virus protease inhibitor |
| 08/25/1992 | US5142051 Viricides special for mutants of herpes viruses |
| 08/25/1992 | US5142041 Cephalosporin intermediates |
| 08/25/1992 | US5141953 Purpuromycin for the treatment of vaginal infections and pharmaceutical dosage forms for said use |
| 08/25/1992 | US5141952 Heterocyclic dicarboxylic acids |
| 08/25/1992 | US5141929 Lipophilic ethers and/or esters of d-desosamine and their compositions as anti-bacteria and anti-fungus agents |
| 08/25/1992 | US5141926 Erythromycin derivatives |
| 08/25/1992 | US5141743 Method for isolating and purifying transferrin and lactoferrin receptor proteins and vaccines containing the same |
| 08/25/1992 | US5141735 Viricides for AIDS treatment |
| 08/25/1992 | CA1306750C Process for the preparation of quinoline carboxylic acide |
| 08/25/1992 | CA1306697C Anti-aids virus agent comprising a streptovaricin c derivative |
| 08/25/1992 | CA1306696C Anti-htlv-i agent comprising a streptovaricin c derivative |
| 08/25/1992 | CA1306695C Composition for treating retrovirus |
| 08/25/1992 | CA1306690C Preparations active against pseudomonas aeruginosa infections and methods of producing them |
| 08/25/1992 | CA1306685C Pharmaceutical composition containing zinc complex of halo-substituted hydroxyquinoline |
| 08/22/1992 | CA2061575A1 Plasmodium falciparum blood-stage antigen, the preparation and use thereof |
| 08/20/1992 | WO1992013943A1 Herpes simplex virus-1 deletion variants and vaccines thereof |
| 08/20/1992 | WO1992013857A1 Process for producing ergolin derivatives |
| 08/20/1992 | WO1992013850A1 Novel gamma-pyrones, gamma-pyridones and gamma-thiopyrones and their use as medicaments and method for producing them |
| 08/20/1992 | WO1992013561A1 Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis |
| 08/20/1992 | WO1992013527A1 Water-dispersible tablets |
| 08/20/1992 | WO1992013525A1 Synthetic membrane vesicles containing functionally active fusion peptides as drug delivery systems |
| 08/20/1992 | WO1992006113A3 Derivatives of gp160 and vaccines based on gp160 or a derivative thereof, containing an adjuvant |
| 08/20/1992 | CA2080119A1 Process for the production of ergoline derivatives |
| 08/20/1992 | CA2061432A1 Cyclic hexapeptide compounds |
| 08/19/1992 | EP0499544A2 Use of tetrahydropiridin-derivatives as inhibitors of angiogenesis |
| 08/19/1992 | EP0499521A1 Inhibitors of N-myristoyltransferase, their preparation process and pharmaceutical compositions containing them |
| 08/19/1992 | EP0499467A2 Use of quinones in the treatment of cancer or AIDS |
| 08/19/1992 | EP0499196A1 Intermediates and process for preparing carbapenem derivatives |
| 08/19/1992 | EP0499003A1 Polypeptides and peptides, particularly recombinant polypeptides and peptides, nucleic acids coding for the same and use of these polypeptides and peptides in the diagnosis of tuberculosis |
| 08/19/1992 | EP0498905A1 Conformational epitopes of human immunodeficiency virus envelope glycoprotein gp120 |
| 08/19/1992 | EP0498871A1 Antimicrobial preservation of plasma |
| 08/19/1992 | EP0498854A1 Antivenoms and methods for making antivenoms |
| 08/19/1992 | EP0498843A1 Oligonucleotide analogs with novel linkages. |
| 08/19/1992 | EP0340245B1 Substituted alkylamides of teicoplanin compounds |
| 08/19/1992 | CN1017902B Process for the preparation of novel cephalosporin derivatives |
| 08/18/1992 | US5139778 Antibiotic ge 2270 factors a1, a2, a3 and h |
| 08/18/1992 | CA1306582C Synthetic polypeptides for detecting mycobacterial infections |
| 08/18/1992 | CA1306580C 3-halovinylglycine antibacterial agents |
| 08/18/1992 | CA1306432C Use of efomycins as performance promoters in animals, efomycins and theirpreparation |
| 08/16/1992 | WO1992014488A1 Structural gene of pneumococcal protein |
| 08/15/1992 | WO1992014755A1 A NOVEL INTEGRIN SPECIFICITY FOR THE HIV Tat PROTEIN |
| 08/15/1992 | CA2101919A1 Integrin specificity for the hiv tat protein |
| 08/15/1992 | CA2061173A1 Compositions comprising tetrahydrothienopyridine derivatives as angiogenesis inhibitors |
| 08/14/1992 | WO1992014454A1 Use of quinones in the treatment of cancer or aids |
| 08/14/1992 | CA2104009A1 Use of quinones in the treatment of cancer or aids |
| 08/13/1992 | WO1992013881A1 Peptides |
| 08/13/1992 | WO1992013560A1 Reagents and methods for identification of vaccines |
| 08/13/1992 | DE4121389A1 Pharmazeutisches produkt zur behandlung von viruserkrankungen A pharmaceutical product for the treatment of viral diseases |
| 08/13/1992 | DE4121388A1 Pharmazeutisches produkt zur behandlung von viruserkrankungen A pharmaceutical product for the treatment of viral diseases |
| 08/13/1992 | DE4103904A1 Neue gamma-pyrone und deren verwendung als arzneimittel sowie verfahren zur herstellung New gamma-pyrones and their use as pharmaceuticals and process for production |
| 08/13/1992 | CA2103788A1 Reagents and methods for identification of vaccines |
| 08/13/1992 | CA2103703A1 Peptides |
| 08/12/1992 | EP0498784A2 Inhibitors of retroviral protease |
| 08/12/1992 | EP0498471A2 Liposomes comprising a guanidino aminoglycoside |
| 08/12/1992 | EP0498290A1 Pyridobenzodiazepines, dipyrido [3,2-b:2',3'-e] [1,4]diazepines and their use in the prevention or treatment of HIV infection |
| 08/12/1992 | EP0498095A1 Sulfonic stilbene derivatives in the treatment of viral diseases |
| 08/12/1992 | EP0497997A1 Synthetic membrane vesicles containing functionally active fusion peptides as drug delivery systems |
| 08/12/1992 | EP0497988A1 Antiviral agent |
| 08/12/1992 | EP0497978A1 Cephalosporin compounds and production thereof |
| 08/12/1992 | EP0497911A1 Recombinant production of lactoperoxidase |
| 08/12/1992 | EP0497835A1 Method for treating hiv and other retroviruses and compounds useful therefor |
| 08/12/1992 | EP0497833A1 C1 inhibitor muteins and uses thereof |
| 08/12/1992 | EP0497816A1 Treatment of hiv infections and compounds useful therein. |
| 08/12/1992 | CN1063507A Enterically transmitted non-a/non-b hepatitis viral agent and characteristic epitopes thereof |
| 08/12/1992 | CN1063416A Avirulent microbes and uses therefor:salmonella typhi |
| 08/12/1992 | CN1017800B Tricyclic compounds |
| 08/12/1992 | CA2060967A1 N-myristoyltransferase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 08/11/1992 | US5138064 Chemical intermediate for penicillin derivative |
| 08/11/1992 | US5138059 Dc-89 compounds and process for their preparation |
| 08/11/1992 | US5138049 Cephalosporin derivative |